Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Barrera

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Biorxiv : the Preprint Server for Biology|November 19, 2025
Uniform processing and analysis of IGVF massively parallel reporter assay data with MPRAsnakeflowJonathan D Rosen, Arjun Devadas Vasanthakumari, Kilian Salomon, et al.
Cell Reports|December 2, 2020
Master Regulators and Cofactors of Human Neuronal Cell Fate Specification Identified by CRISPR Gene Activation ScreensJoshua B Black, Sean R McCutcheon, Shataakshi Dube, et al.
Open Forum Infectious Diseases|October 30, 2024
Immune Reconstitution Inflammatory Syndrome in a Patient With Cutaneous Leishmaniasis and HIV: A Diagnostic Challenge for Clinicians Caring for a Migrant Population in the United StatesAlejandro De La Hoz, Nirupa Gadi, Christina G Lopez, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
SMARCA2 is an essential and potent cofactor for a specific subset of the glucocorticoid response in A549 cellsSchuyler M Melore, D Dewran Koçak, Keith Siklenkla, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Modeling gene regulatory perturbations via deep learning from high-throughput reporter assaysRevathy Venukuttan, Richard Doty, Alexander Thomson, et al.
Rheumatology (Oxford, England)|October 3, 2017
52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritisPaul Emery, Jirí Vencovský, Anna Sylwestrzak, et al.
Annals of the Rheumatic Diseases|July 8, 2015
A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapyPaul Emery, Jiří Vencovský, Anna Sylwestrzak, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Characterization and bioinformatic filtering of ambient gRNAs in single-cell CRISPR screens using CLEANSERSiyan Liu, Marisa C Hamilton, Thomas Cowart, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Activation of the imprinted Prader-Willi Syndrome locus by CRISPR-based epigenome editingDahlia Rohm, Joshua B Black, Sean R McCutcheon, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
Machine learning methods for predicting guide RNA effects in CRISPR epigenome editing experimentsWancen Mu, Tianyou Luo, Alejandro Barrera, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|November 19, 2025
Uniform processing and analysis of IGVF massively parallel reporter assay data with MPRAsnakeflowJonathan D Rosen, Arjun Devadas Vasanthakumari, Kilian Salomon, et al.
Cell Reports|December 2, 2020
Master Regulators and Cofactors of Human Neuronal Cell Fate Specification Identified by CRISPR Gene Activation ScreensJoshua B Black, Sean R McCutcheon, Shataakshi Dube, et al.
Open Forum Infectious Diseases|October 30, 2024
Immune Reconstitution Inflammatory Syndrome in a Patient With Cutaneous Leishmaniasis and HIV: A Diagnostic Challenge for Clinicians Caring for a Migrant Population in the United StatesAlejandro De La Hoz, Nirupa Gadi, Christina G Lopez, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
SMARCA2 is an essential and potent cofactor for a specific subset of the glucocorticoid response in A549 cellsSchuyler M Melore, D Dewran Koçak, Keith Siklenkla, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Modeling gene regulatory perturbations via deep learning from high-throughput reporter assaysRevathy Venukuttan, Richard Doty, Alexander Thomson, et al.
Rheumatology (Oxford, England)|October 3, 2017
52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritisPaul Emery, Jirí Vencovský, Anna Sylwestrzak, et al.
Annals of the Rheumatic Diseases|July 8, 2015
A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapyPaul Emery, Jiří Vencovský, Anna Sylwestrzak, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Characterization and bioinformatic filtering of ambient gRNAs in single-cell CRISPR screens using CLEANSERSiyan Liu, Marisa C Hamilton, Thomas Cowart, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Activation of the imprinted Prader-Willi Syndrome locus by CRISPR-based epigenome editingDahlia Rohm, Joshua B Black, Sean R McCutcheon, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
Machine learning methods for predicting guide RNA effects in CRISPR epigenome editing experimentsWancen Mu, Tianyou Luo, Alejandro Barrera, et al.
Pageof 9